Monday, August 20, 2018
Company News: Page (1) of 1 - 02/14/18 Email this story to a friend. email article Print this page (Article printing at page facebook
US Congressman Dave Brat visits Veritas Collaborative; House and Senate Bills support access to care
(February 14, 2018)
US Congressman Dave Brat visits Veritas Collaborative; House and Senate Bills support access to care

Congressman Dave Brat (VA-07) visited the Richmond, VA location of Veritas Collaborative, a specialty healthcare system for the treatment of eating disorders, on February 12, 2018. The Representative met with Executive Director Elisha Contner Wilkins along with other key members of the Veritas Collaborative staff and toured the medical and outpatient services facility in Henrico County.

“Eating disorders are real, complex medical and psychiatric illnesses that can have serious consequences for health, productivity, and relationships that must be addressed at the federal level," said Congressman Brat. “We need to help all persons with eating disorders get access to the healthcare coverage they need to recover from the disease. That is why I am supporting the stabilization bill co-authored by Senators Alexander and Murray and the reinsurance bill co-authored by Representatives Costello and Peterson."

Designed to help the estimated 30 million people suffering from eating disorders throughout the United States, provisions in both bills will enhance the ability of states to address healthcare access for this population. The Alexander/Murray bill provides for decreasing overall premium prices and creating more flexibility for all states to design better marketplace plans. The Costello/Peterson bill provides $30 billion for three years to help states offset insurance costs for sicker populations.

As a member of the Eating Disorders Coalition and Residential Eating Disorders Consortium, Veritas Collaborative is committed to driving the standard of care in eating disorders treatment so individuals and families can thrive.

After his visit, Congressman Brat stated, “Eating disorders impact all age groups, races, ethnicities, and socioeconomic groups in the United States. Tragically, the lack of awareness and understanding in our communities too often leaves those who struggle with eating disorders alone and without proper treatment. I am proud of the work being done at Veritas Collaborative. Their multidisciplinary approach to treatment marks a step forward in improving the lives of those affected by eating disorder illnesses."

About Veritas Collaborative
Veritas Collaborative is a specialty healthcare system for the treatment of eating disorders. Veritas provides a range of individualized, evidence-based services for patients 8 years of age and older, including inpatient, acute residential, partial hospitalization, and intensive outpatient levels of care in a gender-diverse and inclusive environment. Veritas envisions a world in which all persons with eating disorders and their families have access to best-practice care and hold hope for a cure. Our multidisciplinary teams of treatment professionals include physicians, psychiatrists, dietitians, therapists, nurses, teachers, culinary team members and therapeutic assistants.

Read the full story at

Page: 1

Related Keywords:
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • The global connected health device market is expected to reach an estimated $36.1 billion by 2023 and is forecast to grow at a CAGR of 21.1% from 2018 to 2023
  • Global Hemodialysis and Peritoneal Dialysis Market to Witness a CAGR of 5.9% during 2018-2024
  • The Alzheimer's Research and Prevention Foundation (ARPF) Announces Second Brain Longevity® Therapy Training Program in Washington D.C.
  • Image Guided Radiotherapy Market to Experience Unfaltering Growth at 15.8% CAGR to Revolutionize the Healthcare Sector by 2023

  • Information Update - Teva Canada expands recall of valsartan drugs to include additional lots, as a precaution
  • /R E P E A T -- Information Update - Teva Canada expands recall of valsartan drugs to include additional lots, as a precaution/
  • Singapore's first clinical trial approval for T cell engineered (TCR) immunotherapy for treatment of Liver cancer
  • ViewRay Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock
  • Mirati Therapeutics Announces Presentation Of KRAS G12C Chemistry Advances At The 255th American Chemical Society (ACS) National Meeting And Exposition

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines